← Back to Analyst Consensus 
ABEO Buy
ABEONA THERAPEUTICS INC.
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 16, 2026 (21 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 18, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| Sep 17, 2026 | Roth Capital | initiate | — → Buy | — | 53% |
| Aug 14, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| May 28, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 19, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 10, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Oct 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Aug 18, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Aug 15, 2025 | Oppenheimer | maintain | Outperform → Outperform | $20 | 52% |
| Jul 16, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Jul 14, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| May 16, 2025 | Stifel | maintain | Buy → Buy | $20 | 53% |
| Apr 30, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $20 | 44% |
| Mar 24, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Mar 5, 2025 | Oppenheimer | initiate | — → Outperform | $16 | 52% |
| Feb 19, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Nov 25, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Oct 31, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Oct 29, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $18 | 50% |
| Aug 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Jul 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Jul 3, 2024 | HC Wainwright & Co. | initiate | — → Buy | $15 | 44% |
| May 30, 2024 | Stifel | initiate | — → Buy | $21 | 53% |
| May 16, 2024 | Cantor Fitzgerald | maintain | Overweight → Overweight | $21 | 50% |
| Apr 23, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $36 | 50% |
| Aug 24, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $38 | 50% |
| Jul 13, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $38 | 50% |
| May 24, 2023 | Alliance Global Partners | reiterate | — → Buy | $20 | 41% |
| Nov 14, 2022 | SVB Leerink | maintain | — → Market Perform | $6 | — |
| Nov 8, 2022 | Cantor Fitzgerald | maintain | — → Overweight | $40 | 50% |
| Aug 11, 2022 | SVB Leerink | maintain | — → Market Perform | $5 | — |
Price Target Trend
Jul 1, 2026 Oct 26, 2026
EPS Estimates
+1y —
0y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days